Toll Free: 1-888-928-9744

Artificial Disc Replacement Systems - Medical Devices Pipeline Assessment, 2017

Published: Aug 1, 2017 | Pages: 183 | Publisher: GlobalData | Industry: Medical Devices | Report Format: Electronic (PDF)

Artificial Disc Replacement Systems - Medical Devices Pipeline Assessment, 2017

Summary

GlobalData's Medical Devices sector report, "Artificial Disc Replacement Systems - Medical Devices Pipeline Assessment, 2017" provides an overview of Artificial Disc Replacement Systems currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Artificial Disc Replacement Systems pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

- Extensive coverage of the Artificial Disc Replacement Systems under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Artificial Disc Replacement Systems and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry

Reasons To Buy

The report enables you to - 
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of Artificial Disc Replacement Systems under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product's current stage of development, territory and estimated launch date
 Table of Contents
1 Table of Contents 2 1.1 List of Tables 6 1.2 List of Figures 8 2 Introduction 9 2.1 Artificial Disc Replacement Systems Overview 9 3 Products under Development 10 3.1 Artificial Disc Replacement Systems - Pipeline Products by Stage of Development 10 3.2 Artificial Disc Replacement Systems - Pipeline Products by Segment 11 3.3 Artificial Disc Replacement Systems - Pipeline Products by Territory 12 3.4 Artificial Disc Replacement Systems - Pipeline Products by Regulatory Path 13 3.5 Artificial Disc Replacement Systems - Pipeline Products by Estimated Approval Date 14 3.6 Artificial Disc Replacement Systems - Ongoing Clinical Trials 15 4 Artificial Disc Replacement Systems - Pipeline Products under Development by Companies 16 4.1 Artificial Disc Replacement Systems Companies - Pipeline Products by Stage of Development 16 4.2 Artificial Disc Replacement Systems - Pipeline Products by Stage of Development 18 5 Artificial Disc Replacement Systems Companies and Product Overview 19 5.1 ALCeraX Medizintechnik GmbH Company Overview 19 5.1.1 ALCeraX Medizintechnik GmbH Pipeline Products & Ongoing Clinical Trials Overview 19 5.2 Amedica Corp Company Overview 20 5.2.1 Amedica Corp Pipeline Products & Ongoing Clinical Trials Overview 20 5.3 AxioMed Spine Corp Company Overview 21 5.3.1 AxioMed Spine Corp Pipeline Products & Ongoing Clinical Trials Overview 21 5.4 City, University of London Company Overview 26 5.4.1 City, University of London Pipeline Products & Ongoing Clinical Trials Overview 26 5.5 Crocker Spinal Technologies, Inc. Company Overview 27 5.5.1 Crocker Spinal Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 27 5.6 DePuy Synthes Inc Company Overview 28 5.6.1 DePuy Synthes Inc Pipeline Products & Ongoing Clinical Trials Overview 28 5.7 Disc Motion Technologies (Inactive) Company Overview 31 5.7.1 Disc Motion Technologies (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 31 5.8 Globus Medical, Inc. Company Overview 32 5.8.1 Globus Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 32 5.9 Integra LifeSciences Holdings Corp Company Overview 33 5.9.1 Integra LifeSciences Holdings Corp Pipeline Products & Ongoing Clinical Trials Overview 33 5.10 Medtronic plc Company Overview 34 5.10.1 Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview 34 5.11 MiMedx Group Inc Company Overview 35 5.11.1 MiMedx Group Inc Pipeline Products & Ongoing Clinical Trials Overview 35 5.12 Nano Interface Technology LLC (Inactive) Company Overview 36 5.12.1 Nano Interface Technology LLC (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 36 5.13 NuVasive Inc Company Overview 37 5.13.1 NuVasive Inc Pipeline Products & Ongoing Clinical Trials Overview 37 5.14 Precision Spine, Inc. Company Overview 39 5.14.1 Precision Spine, Inc. Pipeline Products & Ongoing Clinical Trials Overview 39 5.15 Ranier Technology Ltd (Inactive) Company Overview 40 5.15.1 Ranier Technology Ltd (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 40 5.16 RE Spine, LLC Company Overview 42 5.16.1 RE Spine, LLC Pipeline Products & Ongoing Clinical Trials Overview 42 5.17 SeaSpine, Inc. Company Overview 43 5.17.1 SeaSpine, Inc. Pipeline Products & Ongoing Clinical Trials Overview 43 5.18 Simplify Medical, Inc. Company Overview 45 5.18.1 Simplify Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 45 5.19 Smart Disc, Inc. Company Overview 48 5.19.1 Smart Disc, Inc. Pipeline Products & Ongoing Clinical Trials Overview 48 5.20 Spinal Kinetics, Inc. Company Overview 49 5.20.1 Spinal Kinetics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 49 5.21 SpinalMotion Inc Company Overview 52 5.21.1 SpinalMotion Inc Pipeline Products & Ongoing Clinical Trials Overview 52 5.22 SpineSmith Holdings, LLC Company Overview 55 5.22.1 SpineSmith Holdings, LLC Pipeline Products & Ongoing Clinical Trials Overview 55 5.23 Synergy Disc Replacement, Inc. Company Overview 57 5.23.1 Synergy Disc Replacement, Inc. Pipeline Products & Ongoing Clinical Trials Overview 57 5.24 Takiron Co Ltd Company Overview 58 5.24.1 Takiron Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 58 5.25 TranS1 Inc Company Overview 59 5.25.1 TranS1 Inc Pipeline Products & Ongoing Clinical Trials Overview 59 5.26 TrueMotion Spine, Inc. Company Overview 60 5.26.1 TrueMotion Spine, Inc. Pipeline Products & Ongoing Clinical Trials Overview 60 5.27 University of South Florida Company Overview 62 5.27.1 University of South Florida Pipeline Products & Ongoing Clinical Trials Overview 62 5.28 Weill Cornell Medical College Company Overview 63 5.28.1 Weill Cornell Medical College Pipeline Products & Ongoing Clinical Trials Overview 63 5.29 Zimmer Biomet Holdings Inc Company Overview 64 5.29.1 Zimmer Biomet Holdings Inc Pipeline Products & Ongoing Clinical Trials Overview 64 6 Artificial Disc Replacement Systems- Recent Developments 66 6.1 Jul 27, 2017: Zimmer Biomet Reports Second Quarter 2017 Financial Results 66 6.2 Jul 27, 2017: Stryker reports second quarter 2017 results 67 6.3 Jul 26, 2017: MiMedx Announces Record Results For The Second Quarter Of 2017 And Raises Full Year Revenue Guidance 68 6.4 Jul 26, 2017: Integra LifeSciences Reports Second Quarter 2017 Financial Results 70 6.5 Jul 24, 2017: CryoLife Reports Second Quarter 2017 Financial Results 71 6.6 Jul 13, 2017: MiMedx Announces that its Second Quarter Revenue Exceeds the Guidance Range 73 6.7 Jul 11, 2017: Zimmer Biomet Announces Leadership Transition 73 6.8 Jul 11, 2017: Zimmer Biomet Reports Certain Preliminary Second Quarter 2017 Results 74 6.9 Jul 11, 2017: Medicrea Reports First Half 2017 Sales 75 6.10 Jul 05, 2017: MiMedx Agreement With AvKARE Expires As Planned Following Completion Of Contract Wind-Down 76 6.11 Jun 13, 2017: Zimmer Biomet Holdings Announces Resolution of FDA Warning Letter Related to Its Zhejiang, China Manufacturing Facility 77 6.12 Jun 08, 2017: Amedica Releases 2016 Preliminary Earnings Report and Business Update 77 6.13 Jun 01, 2017: NuVasive Appoints Skip Kiil As Executive Vice President, International 79 6.14 May 31, 2017: Depuy Synthes and Ethicon to Showcase Intra Operative Solutions Aiming to Mitigate Surgical Site Infection During Efort Congress 80 6.15 May 25, 2017: Medtronic Reports Fourth Quarter and Fiscal Year 2017 Financial Results 81 6.16 May 22, 2017: NuVasive Announces Educational Initiatives In Support Of Spine's Fastest Growing Spinal Deformity Portfolio 84 6.17 May 11, 2017: Alphatec Reports First Quarter 2017 Financial Results 85 6.18 May 08, 2017: New long-term data on the effect of lumbar total disc replacement on adjacent level degeneration reinforces outcomes from previous studies 86 6.19 May 04, 2017: Orthofix International Reports First Quarter 2017 Financial Results 87 6.20 May 03, 2017: Globus Medical Reports First Quarter 2017 Results 88 6.21 Apr 28, 2017: MiMedx Announces Record Results For First Quarter Of 2017 89 6.22 Apr 27, 2017: Zimmer Biomet Reports First Quarter 2017 Financial Results 91 6.23 Apr 27, 2017: RTI Surgical Announces 2017 First Quarter Results 92 6.24 Apr 26, 2017: Integra LifeSciences Reports First Quarter 2017 Financial Results 93 6.25 Apr 26, 2017: CryoLife Reports First Quarter 2017 Financial Results 94 6.26 Apr 25, 2017: Stryker reports first quarter 2017 results 95 6.27 Apr 25, 2017: NuVasive Announces First Quarter 2017 Financial Results 96 6.28 Apr 24, 2017: Amedica Announces Regulatory Clearance to Market and Sell Valeo Silicon Nitride Spinal Implants in Australia 97 6.29 Apr 19, 2017: Amedica Announces Delayed Filing of Annual Report on Form 10-K and Receipt of Nasdaq Letter 98 6.30 Apr 13, 2017: MiMedx Announces First Quarter 2017 Revenue to Exceed High End of Guidance 98 6.31 Apr 13, 2017: Medicrea Releases First Quarter Sales For 2017 99 6.32 Apr 12, 2017: Simplify Medical Announces First Patient Treated in U.S. Pivotal Trial Of MRI-Optimized Simplify Cervical Artificial Spinal Disc Used at Two Adjacent Levels 100 6.33 Apr 12, 2017: Brian May Joins Spine Wave as Executive Vice President, Research and Development 101 6.34 Mar 30, 2017: Medicrea Announces 2016 Annual Results 101 6.35 Mar 24, 2017: Alphatec Completes its Senior Leadership Team with Appointment of Brian Snider, Executive Vice President, Strategic Marketing and Product Development 102 6.36 Mar 19, 2017: MiMedx Announces The Addition Of Luis A. Aguilar To Its Board Of Directors 104 6.37 Mar 15, 2017: Alphatec Holdings Announces Fourth Quarter and Full Year 2016 Financial Results 105 6.38 Mar 08, 2017: Study Finds Wide Use of Computed Tomography (CT) for Post-Operative Assessment of Spine Surgery, Despite Radiation Risks for Patients 107 6.39 Feb 27, 2017: Amedica Announces Results of Independent Femoral Head Wear Testing 108 6.40 Feb 27, 2017: Orthofix International Reports Fourth Quarter and Fiscal 2016 Financial Results 108 6.41 Feb 27, 2017: Globus Medical Reports Full Year and Fourth Quarter 2016 Results 109 6.42 Feb 23, 2017: RTI Surgical Announces 2016 Fourth Quarter, Full Year Results; Initiates Actions to Improve Execution and Return to Profitable Growth 110 6.43 Feb 23, 2017: MiMedx Announces 2016 Record Results 113 6.44 Feb 23, 2017: Integra LifeSciences Reports Fourth Quarter and Full-Year 2016 Financial Results and Updates 2017 Full-Year Guidance 115 6.45 Feb 21, 2017: Medtronic Reports Third Quarter Financial Results 116 6.46 Feb 15, 2017: CryoLife Reports Fourth Quarter and Full Year 2016 Financial Results 119 6.47 Feb 14, 2017: Alphatec Spine Announces Appointment of David H. Mowry to its Board of Directors 120 6.48 Feb 09, 2017: NuVasive Reports Fourth Quarter And Full Year 2016 Financial Results 121 6.49 Feb 06, 2017: Medtronic Awarded U.S. Department of Veterans Affairs National Contracts for Home Telehealth Technologies, with Three Other Vendors 122 6.50 Jan 31, 2017: Zimmer Biomet Reports Fourth Quarter and Full-Year 2016 Financial Results 123 6.51 Jan 26, 2017: RTI Surgical Names Camille Farhat Chief Executive Officer 124 6.52 Jan 24, 2017: Stryker reports 2016 results and 2017 outlook 125 6.53 Jan 18, 2017: Orthofix Announces Resolution of SEC Investigations 126 6.54 Jan 17, 2017: Zimmer Biomet Announces Americas Leadership Transition 127 6.55 Jan 17, 2017: RTI Surgical Extends Deadline for Nominating Directors to the Board 127 6.56 Jan 12, 2017: Zimmer Biomet Announces Resolution with DOJ and SEC Regarding Previously Disclosed Legacy Biomet FCPA Matters 127 6.57 Jan 12, 2017: Medicrea Releases Annual Sales for 2016 128 6.58 Jan 10, 2017: Stryker provides 2016 preliminary net sales results 128 6.59 Jan 10, 2017: Zimmer Biomet Announces Fourth Quarter and Full-Year 2016 Preliminary Sales Results 130 6.60 Jan 10, 2017: Orthofix Announces Preliminary 2016 Fourth Quarter and Full Year Net Sales Results 130 6.61 Jan 10, 2017: Globus Medical Reports Preliminary Fourth Quarter and Full Year Sales Results 131 6.62 Jan 09, 2017: NuVasive Announces Select Preliminary Unaudited Full Year 2016 Financial Results and 2017 Outlook 131 6.63 Jan 09, 2017: MiMedx Fourth Quarter 2016 Revenue in Upper Range of Guidance 132 6.64 Dec 16, 2016: MiMedx 2017 Guidance Forecasts Revenue Growth In Excess Of 21% And Operating Earnings Growth In Excess Of 90% 134 6.65 Dec 14, 2016: RTI Surgical Names Robert P. Jordheim Interim CEO 135 6.66 Dec 14, 2016: Zimmer Biomet Update on Product Supply Matters and Responsive Statement on Recently Completed FDA Inspection 135 6.67 Dec 13, 2016: Orthofix Announces Appointment of Alex Lukianov to Board of Directors 136 6.68 Dec 12, 2016: Alphatec Holdings appoints new CEO 136 6.69 Dec 12, 2016: Alphatec Holdings Announces Board and Executive Leadership Changes 137 6.70 Dec 05, 2016: Integra LifeSciences announces management changes 139 6.71 Dec 05, 2016: Integra LifeSciences Announces Key Executive Appointments 140 6.72 Nov 24, 2016: Spineart Announces the Publication of Clinical Data for its Baguera C Artifical Cervical Disc Prosthesis 141 6.73 Nov 22, 2016: Medtronic Reports Second Quarter Financial Results 141 6.74 Nov 22, 2016: Amedica appoints vice president of sales and marketing 144 6.75 Nov 22, 2016: Amedica Announces New Sales Leadership and Provides Regulatory Updates 145 6.76 Nov 16, 2016: Medtronic Releases FY16 Integrated Performance Report 146 6.77 Nov 15, 2016: CEVA to work with Medtronic for distribution facility construction 146 6.78 Nov 10, 2016: Amedica Reports Third Quarter 2016 Financial Results 147 6.79 Nov 09, 2016: Alphatec Holdings Announces Third Quarter 2016 Revenue and Financial Results 148 6.80 Nov 08, 2016: Globus Medical Reports Third Quarter 2016 Results 151 6.81 Nov 03, 2016: Inaugural Lumbar Total Disc Replacement Summit Yields Surgeon Consensus on Lumbar TDR as a Standard of Care for Lumbar DDD 151 6.82 Nov 03, 2016: MiMedx Announces USP-NF Monograph For dHACM Allografts Has Published 152 6.83 Oct 31, 2016: Zimmer Biomet Reports Third Quarter 2016 Financial Results 153 6.84 Oct 31, 2016: Orthofix International Reports Third Quarter 2016 Financial Results 154 6.85 Oct 27, 2016: Stryker reports third quarter 2016 results 155 6.86 Oct 27, 2016: MiMedx Announces Third Quarter 2016 Results 156 6.87 Oct 27, 2016: Integra LifeSciences Reports Third Quarter 2016 Financial Results 159 6.88 Oct 26, 2016: Zimmer Biomet Announces Positive Comparative Data from 7-Year Follow-Up Study of Mobi-C Cervical Disc Prosthesis for Cervical Disc Replacement 160 6.89 Oct 26, 2016: CryoLife Reports Third Quarter 2016 Financial Results 161 6.90 Oct 25, 2016: Zimmer Biomet's Mobi-C Cervical Disc Becomes Most Widely Covered Intervertebral Disc Prosthesis for Cervical Disc Replacement 162 6.91 Oct 25, 2016: RTI Surgical Announces 2016 Third Quarter Results 163 6.92 Oct 25, 2016: James W. Bullock Joins CryoLife Board of Directors 164 6.93 Oct 25, 2016: NuVasive Reports Third Quarter 2016 Financial Results 165 6.94 Oct 10, 2016: MiMedx Third Quarter 2016 Revenue Exceeds Upper End of Guidance 166 6.95 Oct 06, 2016: Amedica Provides Business Update 167 6.96 Oct 06, 2016: Medicrea Announces 2016 Third-Quarter Sales 168 6.97 Oct 05, 2016: Amedica Announces Workforce Reduction 169 6.98 Oct 05, 2016: Alphatec Holdings Announces Company Updates 169 6.99 Sep 22, 2016: Medicrea Announces Results for the 1st Half of 2016 170 6.100 Sep 15, 2016: Alphatec Holdings Announces Company Updates 171 6.101 Sep 15, 2016: Medtronic Names Mark Ploof Senior Vice President of Global Operations and Business Services 172 6.102 Sep 12, 2016: NuVasive Names Jason M. Hannon President and Chief Operating Officer; Patrick S. Miles Assumes Role of Vice Chairman 173 6.103 Sep 06, 2016: MiMedx Reaffirms Q3 and Full Year 2016 Guidance 174 6.104 Sep 06, 2016: CryoLife Appoints James McDermid as Chief Human Resources Officer 174 6.105 Aug 25, 2016: Medtronic Reports First Quarter Financial Results 175 6.106 Aug 19, 2016: Amedica Announces Receipt of Nasdaq Notice of Bid Price Deficiency 178 6.107 Aug 15, 2016: RTI Surgical Announces CEO Brian Hutchison to Retire 178 7 Appendix 180 7.1 Methodology 180 7.2 About GlobalData 183 7.3 Contact Us 183 7.4 Disclaimer 183
List of Tables
Table 1: Artificial Disc Replacement Systems - Pipeline Products by Stage of Development 10 Table 2: Artificial Disc Replacement Systems - Pipeline Products by Segment 11 Table 3: Artificial Disc Replacement Systems - Pipeline Products by Territory 12 Table 4: Artificial Disc Replacement Systems - Pipeline Products by Regulatory Path 13 Table 5: Artificial Disc Replacement Systems - Pipeline Products by Estimated Approval Date 14 Table 6: Artificial Disc Replacement Systems - Ongoing Clinical Trials 15 Table 7: Artificial Disc Replacement Systems Companies - Pipeline Products by Stage of Development 16 Table 8: Artificial Disc Replacement Systems - Pipeline Products by Stage of Development 18 Table 9: ALCeraX Medizintechnik GmbH Pipeline Products & Ongoing Clinical Trials Overview 19 Table 10: ConCera - Product Status 19 Table 11: ConCera - Product Description 19 Table 12: Amedica Corp Pipeline Products & Ongoing Clinical Trials Overview 20 Table 13: Spartacus - Product Status 20 Table 14: Spartacus - Product Description 20 Table 15: AxioMed Spine Corp Pipeline Products & Ongoing Clinical Trials Overview 21 Table 16: Freedom Cervical Disc - Product Status 21 Table 17: Freedom Cervical Disc - Product Description 21 Table 18: Freedom Lumbar Disc - Product Status 22 Table 19: Freedom Lumbar Disc - Product Description 22 Table 20: AxioMed Spine Corp - Ongoing Clinical Trials Overview 23 Table 21: Freedom Lumbar Disc - An IDE Study of the Freedom Lumbar Disc in the Treatment of Lumbar Degenerative Disc Disease 24 Table 22: Freedom Cervical Disc - Freedom Cervical Disc Use in the Treatment of Cervical Degenerative Disc Disease 25 Table 23: City, University of London Pipeline Products & Ongoing Clinical Trials Overview 26 Table 24: Artificial Intervertebral Disc Prosthesis - Product Status 26 Table 25: Artificial Intervertebral Disc Prosthesis - Product Description 26 Table 26: Crocker Spinal Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 27 Table 27: FlexBac - Product Status 27 Table 28: FlexBac - Product Description 27 Table 29: DePuy Synthes Inc Pipeline Products & Ongoing Clinical Trials Overview 28 Table 30: Discover Artificial Cervical Disc - Product Status 28 Table 31: Discover Artificial Cervical Disc - Product Description 28 Table 32: DePuy Synthes Inc - Ongoing Clinical Trials Overview 29 Table 33: Discover Artificial Cervical Disc - Treatment of Cervical Radiculopathy with Arthroplasty Compared with Discectomy with Fusion And Cage (ACDF). Clinical, Radiological And Biomechanical Aspects. A Randomized Multi-center Study 30 Table 34: Disc Motion Technologies (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 31 Table 35: Inlign PL - Product Status 31 Table 36: Inlign PL - Product Description 31 Table 37: Globus Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 32 Table 38: Triumph Lumbar Disc - Product Status 32 Table 39: Triumph Lumbar Disc - Product Description 32 Table 40: Integra LifeSciences Holdings Corp Pipeline Products & Ongoing Clinical Trials Overview 33 Table 41: eDISC - Product Status 33 Table 42: eDISC - Product Description 33 Table 43: Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview 34 Table 44: Maverick Artificial Lumbar Disc - Product Status 34 Table 45: Maverick Artificial Lumbar Disc - Product Description 34 Table 46: MiMedx Group Inc Pipeline Products & Ongoing Clinical Trials Overview 35 Table 47: SaluDisc - Product Status 35 Table 48: SaluDisc - Product Description 35 Table 49: Nano Interface Technology LLC (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 36 Table 50: Spinal Disc - Product Status 36 Table 51: Spinal Disc - Product Description 36 Table 52: NuVasive Inc Pipeline Products & Ongoing Clinical Trials Overview 37 Table 53: Cerpass Cervical Total Disc Replacement System - Product Status 37 Table 54: Cerpass Cervical Total Disc Replacement System - Product Description 37 Table 55: XL TDR - Product Status 38 Table 56: XL TDR - Product Description 38 Table 57: Precision Spine, Inc. Pipeline Products & Ongoing Clinical Trials Overview 39 Table 58: Disc Replacement Device - Product Status 39 Table 59: Disc Replacement Device - Product Description 39 Table 60: Ranier Technology Ltd (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 40 Table 61: Cadisc-C - Product Status 40 Table 62: Cadisc-C - Product Description 40 Table 63: Cadisc-L - Product Status 41 Table 64: Cadisc-L - Product Description 41 Table 65: RE Spine, LLC Pipeline Products & Ongoing Clinical Trials Overview 42 Table 66: Intervertebral Disc - Product Status 42 Table 67: Intervertebral Disc - Product Description 42 Table 68: SeaSpine, Inc. Pipeline Products & Ongoing Clinical Trials Overview 43 Table 69: Catalina - Product Status 43 Table 70: Catalina - Product Description 43 Table 71: La Jolla - Product Status 44 Table 72: La Jolla - Product Description 44 Table 73: Simplify Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 45 Table 74: Simplify Disc - Product Status 45 Table 75: Simplify Disc - Product Description 45 Table 76: Simplify Medical, Inc. - Ongoing Clinical Trials Overview 46 Table 77: Simplify Disc - Clinical Study Protocol for the Investigation of the Simplify Cervical Artificial Disc 47 Table 78: Simplify Disc - Clinical Study Protocol for the Investigation of the Two Level Simplify Cervical Artificial Disc 47 Table 79: Smart Disc, Inc. Pipeline Products & Ongoing Clinical Trials Overview 48 Table 80: Spinal Replacement Disc - Product Status 48 Table 81: Spinal Replacement Disc - Product Description 48 Table 82: Spinal Kinetics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 49 Table 83: M6-C Artificial Cervical Disc - Product Status 49 Table 84: M6-C Artificial Cervical Disc - Product Description 49 Table 85: Spinal Kinetics, Inc. - Ongoing Clinical Trials Overview 50 Table 86: M6-C Artificial Cervical Disc - Prospective, Concurrently Controlled, Multi-Center Study to Evaluate the Safety and Effectiveness of the Spinal Kinetics M6-C Artificial Cervical Disc Compared to Anterior Cervical Discectomy and Fusion (ACDF) for the Treatment of Symptomatic Cervical Radiculopathy 51 Table 87: SpinalMotion Inc Pipeline Products & Ongoing Clinical Trials Overview 52 Table 88: Kineflex Lumbar Disc - Product Status 52 Table 89: Kineflex Lumbar Disc - Product Description 52 Table 90: Kineflex|C Cervical Disc - Product Status 53 Table 91: Kineflex|C Cervical Disc - Product Description 53 Table 92: Kineflex|CI Disc - Product Status 53 Table 93: Kineflex|CI Disc - Product Description 54 Table 94: SpineSmith Holdings, LLC Pipeline Products & Ongoing Clinical Trials Overview 55 Table 95: Biologically Active Artificial Disc - Product Status 55 Table 96: Biologically Active Artificial Disc - Product Description 55 Table 97: Cervical Disc - Product Status 56 Table 98: Cervical Disc - Product Description 56 Table 99: Synergy Disc Replacement, Inc. Pipeline Products & Ongoing Clinical Trials Overview 57 Table 100: Synergy-Disc - Product Status 57 Table 101: Synergy-Disc - Product Description 57 Table 102: Takiron Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 58 Table 103: FABRICUBE - Product Status 58 Table 104: FABRICUBE - Product Description 58 Table 105: TranS1 Inc Pipeline Products & Ongoing Clinical Trials Overview 59 Table 106: TranS1 - Percutaneous Disc Replacement (PDR) - Product Status 59 Table 107: TranS1 - Percutaneous Disc Replacement (PDR) - Product Description 59 Table 108: TrueMotion Spine, Inc. Pipeline Products & Ongoing Clinical Trials Overview 60 Table 109: TrueMotion Cervical D6 - Product Status 60 Table 110: TrueMotion Cervical D6 - Product Description 60 Table 111: TrueMotion Lumbar Device - Product Status 61 Table 112: TrueMotion Lumbar Device - Product Description 61 Table 113: University of South Florida Pipeline Products & Ongoing Clinical Trials Overview 62 Table 114: Spine Disc Prosthesis - Product Status 62 Table 115: Spine Disc Prosthesis - Product Description 62 Table 116: Weill Cornell Medical College Pipeline Products & Ongoing Clinical Trials Overview 63 Table 117: Biological Spinal Implant - Product Status 63 Table 118: Biological Spinal Implant - Product Description 63 Table 119: Zimmer Biomet Holdings Inc Pipeline Products & Ongoing Clinical Trials Overview 64 Table 120: Min T Lumbar Artificial Disc - Product Status 64 Table 121: Min T Lumbar Artificial Disc - Product Description 64 Table 122: Rescue Cervical Disc - Product Status 65 Table 123: Rescue Cervical Disc - Product Description 65 Table 124: Glossary 182


List of Figures
Figure 1: Artificial Disc Replacement Systems - Pipeline Products by Stage of Development 10 Figure 2: Artificial Disc Replacement Systems - Pipeline Products by Segment 11 Figure 3: Artificial Disc Replacement Systems - Pipeline Products by Territory 12 Figure 4: Artificial Disc Replacement Systems - Pipeline Products by Regulatory Path 13 Figure 5: Artificial Disc Replacement Systems - Pipeline Products by Estimated Approval Date 14 Figure 6: Artificial Disc Replacement Systems - Ongoing Clinical Trials 15

To request a free sample copy of this report, please complete the form below.

This website is secure and your personal details are safe. Privacy policy

Global Automated Test Equipment (ATE) market is expected to be valued at USD 4.48 billion by 2020, as per a new research report by Radiant Insights, Inc. Increasing design complexity coupled with need for effective testing is expected to drive the gl

Read More...

Global data center UPS market size is estimated to reach USD 5.7 billion by 2020, as per a new research report by Radiant Insights, Inc. Declining tolerance levels pertaining to data loss along with amplifying acceptance of cloud computing is likely

Read More...

Global Aerial Work Platform (AWP) truck market is expected to be valued at USD 8,003.7 million by 2022, as per a new research report by Radiant Insights, Inc. Rapid infrastructure growth due to rising real estate investment is expected to drive the i

Read More...

Global commercial drone market size is estimated to reach USD 2,069.6 million by 2022, as per a new research report by Radiant Insights, Inc. Increasing application of these machines in various industry sectors such as military, agriculture and energ

Read More...

Global sorbitol market size is anticipated to be reach USD 3.99 billion by 2020, as per a new research report by Radiant Insights, Inc. Growing consumer perception towards product benefits derived from natural ingredients is expected to drive the dem

Read More...
Choose License Type
Single User - US $4000
Multi User - US $8000
Why Choose Us

24/5 Research support

Get your queries resolved from an industry expert. Request for a free product review before report purchase.

Phone: 1-415-349-0054

Toll Free: 1-888-928-9744

Email: [email protected]

Custom research service

Speak to the report author to design an exclusive study to serve your research needs.

Quality assurance

A testimonial for service excellence represented in the form of BBB "A" Accreditation.

Information security

Your personal and confidential information is safe and secure.

verify